Downtrend on the daily chart: below its 50- and 200-day averages · 50-day above the 200-day · SuperTrend down since Jul 8 · below the Ichimoku cloud · RSI 41 · MACD below its signal
None of the 29 investors followed here reported a position in TRUFF in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a TRUFF trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for TRUFF.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -25.0 | 8.3 | 7.7 | 107.1 | 3.4 | -23.3 | -4.3 | -9.1 | 5.0 | -9.5 | +18.7% | ||
| 2025 | -3.1 | -6.5 | -20.7 | 8.7 | -8.0 | 4.3 | 29.2 | -9.7 | -7.1 | -15.4 | -13.6 | -15.8 | −50.0% |
| 2024 | 2.2 | -8.7 | 4.8 | -4.5 | -7.1 | -10.3 | 5.7 | -16.2 | -9.7 | -14.3 | 41.7 | -5.9 | −28.9% |
| 2023 | 20.0 | 47.4 | -27.0 | -17.9 | -11.6 | 13.1 | -8.7 | -6.3 | -3.4 | -31.6 | 25.6 | -8.2 | −30.8% |
| 2022 | 3.8 | -8.3 | -12.0 | -3.4 | -2.4 | -25.3 | 61.3 | 0.0 | -35.0 | 9.2 | -8.5 | 0.0 | −38.1% |
| 2021 | -4.1 | -26.2 | 6.9 | -11.8 | -0.8 | -8.2 | -6.7 | -22.4 | -6.1 | -32.0 | 1.0 | −71.6% |
No analyst coverage for this instrument.
Rhelion Life Sciences Corp. engages in the research and development of psychedelic drug in Netherlands, Canada, and the United States. Its products also include PEX010, a natural psilocybin drug candidate. It also engages in the production, growth, and sale of functional mushrooms and mushroom home grow kits to the recreational market in North America and Europe, as well as selection, distribution, and export of truffles. The company was formerly known as Red Light Holland Corp. and changed its name to Rhelion Life Sciences Corp. in August 2026. Rhelion Life Sciences Corp. is based in Toronto, Canada.